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Introduction. Antimicrobial resistance represents a global burden and crisis but also a 
significant threat to public health nowadays. Healthcare-associated infections with multi-
drug resistant (MDR) bacteria lead to increased morbidity rates, with a continuous in-
creasing incidence at global levels. The selective pressure created by the widespread use 
of antibiotics might be the main explanation of this burden. It is known that P. aeruginosa 
is one of the most frequent bacteria involved in the etiology of ventilator-associated pneu-
monia, with a relative high prevalence in patients admitted to intensive care units and a 
high mortality rate. Studies showed that the presence of MDR strains could be an im-
portant predictor of hospital death. The aim of this study was to evaluate antimicrobial 
resistance patterns of P. aeruginosa strains isolated from various clinical specimens of 
hospitalized patients 
Material and methods. We conducted a retrospective study during January–December 
2020. Isolation of P. aeruginosa strains was performed on selective media for Gram-nega-
tive. Identification of strains was done both by conventional methods and by automated 
methods using Vitek®2 Compact. Antibiotic susceptibility testing was done using the Vi-
tek®2Compact, but also by Kirby-Bauer method. Interpretation susceptibility was per-
formed according to the EUCAST (European Committee on Antimicrobial Susceptibility 
Testing).   
Results. They were analyzed 118 isolates from patients hospitalized in surgical wards, 
51.2% male, respectively 48.8% women. These strains were isolated from different patho-
logical products: lower tract respirator (39.9%), pus (35.6%), urine (15.4%), central ve-
nous catheter insertion (2.7), blood (2.1%) and other secretions (4.3%). 
P. aeruginosa strains showed the following levels of antibiotic resistance, respectively,  
70.7% to ticarcillin, 58.7% to piperacillin, while resistance to the penicillins combined 
with beta-lactamase inhibitors, piperacillin with tazobactam was 43.5%. Resistance to an-
tipseudomonal cephalosporins was 37.9% to ceftazidime and 50.8% to cefepime, while 
the level of resistance to carbapenems was 55.9 % to imipenem and 27.1% to meropenem. 
Resistance to aminoglycosides was 51.9% to gentamicin, 58.4% to tobramycin and 34.4% 
to amikacin. 62.8% of strains showed resistance to fluoroquinolones (ciprofloxacin). 
Conclusion. Multidrug resistance is common and increasing. Occurrence of these MDR 
strain in clinical care settings makes them difficult and expensive to treat because these 
drug resistant strain are exhibit resistance to essentially all reliable antipseudomonal an-
tibiotics. The available clinical solution for antibiotic resistance Pseudomonas aeruginosa 
infections requires a precise diagnostic and combination antibiotic therapy based on di-
agnostics. Judicious administration of antibiotics in combination with nosocomial infec-
tion control measures need to be introduced in hospitals to prevent the circulation of these 
multidrugresistant strains. 
This paper has been written within the framework of the project: 20.80009.8007.09 "Study-
ing the mechanisms of antimicrobial resistance in gram-negative bacilli in order to 
strengthen the national surveillance system". 
 
 
 
 
 
